Increased fetal cardiac natriuretic peptide secretion in type-1 diabetic pregnancies

Acta Obstetricia et Gynecologica Scandinavica

Volumn 87, Issue 3, 2008, Pages 307-312

  Girsen, Anna ^a   Ala Kopsala, Minna ^a   Mäkikallio, Kaarin ^a   Vuolteenaho, Olli ^a   Räsänen, Juha ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cardiac function; Heart; Hemodynamics; Physiology

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; NATRIURETIC FACTOR; PROTEIN NT PROANP; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FETUS; GESTATIONAL AGE; GLYCEMIC CONTROL; HORMONE RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NEWBORN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; UMBILICAL ARTERY; UMBILICAL CORD BLOOD;

EID: 39849099068     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340801899990     Document Type: Article

References (36)

1. 1 Vela‐Huerta MM, Vargas‐Origel A, Olvera‐Lopez A. Asymmetrical septal hypertrophy in newborn infants of diabetic mothers. Am J Perinatol. 2000 ; 17: 89–94.
2. 2 Sardesai MG, Gray AA, McGrath MM, Ford SE. Fatal hypertrophic cardiomyopathy in the fetus of a woman with diabetes. Obstet Gynecol. 2001 ; 98: 925–7.
3. 3 Abu‐Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol. 2004 ; 25: 137–40.
4. 4 Rasanen J, Kirkinen P. Growth and function of human fetal heart in normal, hypertensive and diabetic pregnancy. Acta Obstet Gynecol Scand. 1987 ; 66: 349–53.
5. 5 Gandhi JA, Zhang XY, Maidman JE. Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am J Obstet Gynecol. 1995 ; 173: 1132–6.
6. 6 Susa JB, McCormick KL, Widness JA, et al. Chronic hyperinsulinemia in the fetal rhesus monkey: effects on fetal growth and composition. Diabetes. 1979 ; 28: 1058–63.
7. 7 Salvesen DR, Higueras MT, Mansur CA, Freeman J, Brudenell JM, Nicolaides KH. Placental and fetal Doppler velocimetry in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol. 1993 ; 168: 645–52.
8. 8 Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 1954 ; 16: 330–42.
9. 9 Vuolteenaho O, Ala‐Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem. 2005 ; 40: 1–36.
10. 10 Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998 ; 339: 321–8.
11. 11 Woods RL. Cardioprotective functions of atrial natriuretic peptide and B‐type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol. 2004 ; 31: 791–4.
12. 12 Gopinath B, Trent RJ, Yu B. Molecular characterisation of neonatal cardiac hypertrophy and its regression. Cardiol Young. 2004 ; 14: 498–505.
13. 13 Mulay S, Conliffe PR, Varma DR. Increased natriuretic peptides in fetal hearts of diabetic rats. J Endocrinol. 1995 ; 146: 255–9.
14. 14 Halse KG, Lindegaard ML, Goetze JP, Damm P, Mathiesen ER, Nielsen LB. Increased plasma pro‐B‐type natriuretic peptide in infants of women with type 1 diabetes. Clin Chem. 2005 ; 51: 2296–302.
15. 15 White P. Classification of obstetric diabetes. Am J Obstet Gynecol. 1978 ; 130: 228–30.
16. 16 Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Pre‐conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996 ; 19: 514–41.
17. 17 Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care. 2006 ; 29: 1744–9.
18. 18 Ala‐Kopsala M, Magga J, Peuhkurinen K, et al. Molecular heterogeneity has a major impact on the measurement of circulating N‐terminal fragments of A‐ and B‐type natriuretic peptides. Clin Chem. 2004 ; 50: 1576–88.
19. 19 Ala‐Kopsala M, Ruskoaho H, Leppaluoto J, et al. Single assay for amino‐terminal fragments of cardiac A‐ and B‐type natriuretic peptides. Clin Chem. 2005 ; 51: 708–18.
20. 20 McKenna K, Smith D, Tormey W, Thompson CJ. Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus. Diabetes Med. 2000 ; 17: 512–7.
21. 21 Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA. The sites of gene expression of atrial, brain, and C‐type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology. 1996 ; 137: 817–24.
22. 22 Thackaberry EA, Bedrick EJ, Goens MB, et al. Insulin regulation in AhR‐null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR‐null females. Toxicol Sci. 2003 ; 76: 407–17.
23. 23 Makikallio K, Vuolteenaho O, Jouppila P, Rasanen J. Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation. 2002 ; 105: 2058–63.
24. 24 Menezes HS, Barra M, Bello AR, Martins CB, Zielinsky P. Fetal myocardial hypertrophy in an experimental model of gestational diabetes. Cardiol Young. 2001 ; 11: 609–13.
25. 25 Sesti G, Sciacqua A, Scozzafava A, et al. Effects of growth hormone and insulin‐like growth factor‐1 on cardiac hypertrophy of hypertensive patients. J Hypertens. 2007 ; 25: 471–7.
26. 26 Rizzo G, Arduini D, Romanini C. Cardiac function in fetuses of type I diabetic mothers. Am J Obstet Gynecol. 1991 ; 164: 837–43.
27. 27 Tsyvian P, Malkin K, Artemieva O, Wladimiroff JW. Assessment of left ventricular filling in normally grown fetuses, growth‐restricted fetuses and fetuses of diabetic mothers. Ultrasound Obstet Gynecol. 1998 ; 12: 33–8.
28. 28 Rizzo G, Arduini D, Capponi A, Romanini C. Cardiac and venous blood flow in fetuses of insulin‐dependent diabetic mothers: evidence of abnormal hemodynamics in early gestation. Am J Obstet Gynecol. 1995 ; 173: 1775–81.
29. 29 Lisowski LA, Verheijen PM, De Smedt MM, Visser GH, Meijboom EJ. Altered fetal circulation in type‐1 diabetic pregnancies. Ultrasound Obstet Gynecol. 2003 ; 21: 365–9.
30. 30 Olofsson P, Lingman G, Marsal K, Sjoberg NO. Fetal blood flow in diabetic pregnancy. J Perinat Med. 1987 ; 15: 545–53.
31. 31 Rasanen J, Kirkinen P, Jouppila P. Fetal aortic blood flow and echocardiographic findings in human pregnancy. Eur J Obstet Gynecol Reprod Biol. 1988 ; 27: 115–24.
32. 32 Girsen A, Ala‐Kopsala M, Makikallio K, Vuolteenaho O, Rasanen J. Cardiovascular hemodynamics and umbilical artery N‐terminal peptide of proB‐type natriuretic peptide in human fetuses with growth restriction. Ultrasound Obstet Gynecol. 2007 ; 29: 296–303.
33. 33 Walther T, Stepan H, Faber R. Dual natriuretic peptide response to volume load in the fetal circulation. Cardiovasc Res. 2001 ; 49: 817–9.
34. 34 Makikallio K, Vuolteenaho O, Jouppila P, Rasanen J. Umbilical artery N‐terminal peptide of proatrial natriuretic peptide in hypertensive pregnancies and fetal acidemia during labor. Obstet Gynecol. 2001 ; 97: 23–8.
35. 35 Bakker J, Gies I, Slavenburg B, Bekers O, Delhaas T, van Dieijen‐Visser M. Reference values for N‐terminal pro‐B‐type natriuretic peptide in umbilical cord blood. Clin Chem. 2004 ; 50: 2465.
36. 36 Bar‐Oz B, Lev‐Sagie A, Arad I, Salpeter L, Nir A. N‐terminal pro‐B‐type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem. 2005 ; 51: 926–7.